The State Drug Affordability Board Is Watching Patent Listings You Haven’t Checked in a Year
On July 1, 2026, a federal judge in Denver blocked Colorado’s price cap on Enbrel. The board that set the
October 2026
The Forum You File In Changes Your Odds More Than the Merits Do
In 2015, a Delaware federal judge looked at prior art covering an antioxidant added to a rivastigmine skin patch and
The Forum You File In Changes Your Odds More Than the Merits Do Read Post »
Why Your PBM’s Generic Substitution Policy Is Six Months Behind the Actual Patent Timeline
The Short Answer Six months is the optimistic case. When Amgen launched the first Humira biosimilar on January 31, 2023,
